Print…

Whole blood, acute myeloid leukemia (AML)

HCMSPB000F-2-AMLEA 0 EUR
HCMSPB000F-2-AML
Whole blood, acute myeloid leukemia (AML)
Whole Blood used for researching the causes, diagnosis, supportive care and treatment of acute myeloid leukemia (AML). Whole blood is collected from IRB-consented donors diagnosed with acute myeloid leukemia (AML).

No pre screening is done on fresh products, but donors are tested on day of collection for Hepatitis B, Hepatitis C, and HIV 1/2.

Storage: Use immediately upon receipt.

Atenção: Intended for only research use and not for direct therapeutic or diagnostic use in human or animals, or for further manufacturing of therapeutic products or devices.
Encomendar

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mais info About VWR